STAGE IIIB BREAST CANCER
Clinical trials for STAGE IIIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat breast cancer: drug combo shows promise
Disease control CompletedThis study tested a drug called alisertib, either alone or combined with the hormone therapy fulvestrant, in 96 postmenopausal women with advanced breast cancer that had stopped responding to standard hormone treatments. The goal was to see if these treatments could shrink tumors…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New drug combo offers Surgery-Free option for elderly breast cancer patients
Disease control CompletedThis study tested a combination of two hormone-blocking drugs (fulvestrant and palbociclib) in 14 elderly patients with hormone-sensitive breast cancer who either could not undergo surgery due to frailty or chose not to have it. The goal was to see if this drug pair could control…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Can fish oil and arthritis drug fight pregnancy breast cancer?
Knowledge-focused CompletedThis study looked at whether two anti-inflammatory drugs—fish oil and celecoxib (a COX-2 inhibitor)—can reduce inflammation and slow tumor growth in pregnancy-associated breast cancer. 42 women with breast cancer took one of these drugs for at least a week before their planned su…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC